home / stock / sprcy / sprcy message board
Subject | By | Source | When |
---|---|---|---|
znewcar1: TRPX 37% v10,3M c.480 f5,71M EOD BO>.4 to close then afterhours pushing to H.65 | znewcar1 | investorshangout | 05/07/2020 11:57:45 PM |
znewcar1: TRPX 33% v1,1M c.613 f7,2M H.627 S.529 | znewcar1 | investorshangout | 02/27/2020 10:22:59 PM |
znewcar1: TRPX 19% v1,3M c1.72 f4,4M Seems like a looser | znewcar1 | investorshangout | 11/14/2019 5:05:58 AM |
whytestocks: $TRPX News Article - Therapix Biosciences Announces Positive Topline Results From Phase | whytestocks | investorshangout | 11/13/2019 3:00:43 PM |
whytestocks: $TRPX News Article - Nasdaq Grants Therapix Biosciences Extension to Comply With Stockh | whytestocks | investorshangout | 08/27/2019 3:05:40 PM |
whytestocks: $TRPX News Article - Therapix Biosciences Announces First Quarter 2019 Condensed Financ | whytestocks | investorshangout | 07/05/2019 8:25:45 PM |
znewcar1: 37.31% v788,503 c9.20 f3,497,138 solid climb BO @7.5 | znewcar1 | investorshangout | 11/05/2018 9:23:01 PM |
News, Short Squeeze, Breakout and More Instantly...
SciSparc Company Name:
SPRCY Stock Symbol:
OTCMKTS Market:
SciSparc Announces Positive Results from Psychedelic-Based Pre-Clinical Trial Results demonstrated that combining SciSparc's CannAmide™ with Clearmind's MEAI has the potential to reduce alcohol consumption PR Newswire TEL AVIV, Israel , March 17, 2022 ...
SciSparc Launches New JV Targeting Discovery of Potential Drugs for Cancers and Infectious Diseases Research builds on studies with support from global experts in the field of small molecule drugs and gene editing PR Newswire TEL AVIV, Israel , March 10, 2022 ...
SciSparc Enters Collaboration for the Development of Innovative Psychedelic-Based Pharmaceuticals PR Newswire TEL AVIV, Israel , March 8, 2022 /PRNewswire/ -- SciSparc Ltd. (NASDAQ: SPRC), a specialty clinical-stage pharmaceutical company focusing on the developm...